Vanguard Group Inc Palatin Technologies Inc Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $8.33 $2.58 Million - $79.6 Million	-9,559,564 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.37 - $0.54 $18,060 - $26,358	48,812 Added 0.51%	9,559,564 $4.4 Million
Q4 2021 Feb 14, 2022	SELL	$0.34 - $0.86 $4,379 - $11,076	-12,880 Reduced 0.14%	9,510,752 $4.87 Million
Q2 2021 Aug 13, 2021	BUY	$0.48 - $0.72 $4.57 Million - $6.86 Million	9,523,632 New	9,523,632 $5.81 Million

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.45M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.